Cleveland Clinic To Lead First Head-to-Head Comparison Of The Two Most Potent Statins

Cleveland Clinic researchers will coordinate the first head-to-head comparison of the two most effective statin medications. The trial intends to start enrollment as early as next week. Statins are the world’s most commonly prescribed drugs and widely used to

treat patients with elevated cholesterol levels. The two drugs, atorvastatin (Lipitor) and rosuvastatin (Crestor), lower LDL (”bad”) cholesterol and raise HDL (”good”) cholesterol.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Statins - Findings Depend On Who Has Funded The Research
  • Researchers At Cleveland Clinic Identify Site Of ‘Dysfunction’ In HDL, Carrier Of Good Cholesterol
  • Cleveland Clinic Medical Guide Helps Women Face Midlife
  • Popular Statins Go Head To Head In New, Global Cholesterol Trial
  • Denosumab Osteoporosis Study Met Primary And All Secondary Bone Mineral Density Endpoints In A Head-to Head Comparison With Weekly Alendronate
  • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.